1 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 2 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Enrolling by invitation 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Gout Initiating Urate-loweringUrate-lowering Therapy: new trials by email Literature Review of Gout Initiating Urate-loweringUrate-lowering Therapy trials Research Report on Gout Initiating Urate-loweringUrate-lowering Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness HLA-B*58:01 Genotyping, Allopurinol Tablet, Febuxostat - Gout Initiating Urate-loweringUrate-lowering Therapy, Gout Arthritis | Phase 4 | Not yet recruiting | Haiphong University of Medicine and Pharmacy | 228 | 2026-01-20 | 2026-01-27 |
| Nurse-Led Telehealth for Gout Nurse-Led Self-Management Support, GP-follow up - Health Literacy, Gout Arthritis | Not applicable | Recruiting | University of Aarhus | 200 | 2025-10-01 | 2025-09-18 |
| The Remote Monitoring of Gout Study Urika, Nurse-led follow-up with telephone consultations. - Gout Initiating Urate-loweringUrate-lowering Therapy | Not applicable | Enrolling by invitation | Diakonhjemmet Hospital | 168 | 2025-06-01 | 2025-06-10 |
| A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202) Genakumab for injection, Colchicine - Gout, Gout Initiating Urate-loweringUrate-lowering Therapy | Phase 2 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 165 | 2023-07-20 | 2025-01-01 |
Gout (3) · Arthritis, Gouty (2) · Hyperuricemia (1) · Stevens-Johnson Syndrome (1)
Arthritis (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Crystal Arthropathies (4) · Genetic Diseases, Inborn (4) · Joint Diseases (4) · Metabolic Diseases (4) · Metabolism, Inborn Errors (4) · Musculoskeletal Diseases (4) · Nutritional and Metabolic Diseases (4) · Purine-Pyrimidine Metabolism, Inborn Errors (4) · Rheumatic Diseases (4) · Chemically-Induced Disorders (1) · Dermatitis (1) · Drug Eruptions (1) · Drug Hypersensitivity (1)
Allopurinol (1) · Colchicine (1) · Febuxostat (1) · Injections (1)
Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Diakonhjemmet Hospital (1) · Haiphong University of Medicine and Pharmacy (1) · University of Aarhus (1)
China (1) · Denmark (1) · Norway (1)
Hejian Zou (1)